Credit Suisse’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-889,268
Closed -$16M 3423
2020
Q2
$16M Buy
889,268
+778,481
+703% +$14M 0.01% 823
2020
Q1
$790K Sell
110,787
-186,057
-63% -$1.33M ﹤0.01% 2271
2019
Q4
$7.09M Buy
296,844
+161,580
+119% +$3.86M 0.01% 1225
2019
Q3
$3.63M Buy
135,264
+73,515
+119% +$1.97M ﹤0.01% 1544
2019
Q2
$1.68M Sell
61,749
-214
-0.3% -$5.81K ﹤0.01% 2042
2019
Q1
$2.15M Buy
61,963
+6,853
+12% +$238K ﹤0.01% 1846
2018
Q4
$1.08M Sell
55,110
-317,902
-85% -$6.21M ﹤0.01% 2237
2018
Q3
$9.93M Sell
373,012
-17,903
-5% -$477K 0.01% 1037
2018
Q2
$14.8M Sell
390,915
-213,408
-35% -$8.06M 0.01% 834
2018
Q1
$19.7M Buy
604,323
+366,464
+154% +$12M 0.02% 732
2017
Q4
$11.6M Buy
237,859
+96,490
+68% +$4.7M 0.01% 951
2017
Q3
$7.64M Buy
141,369
+33,424
+31% +$1.81M 0.01% 1160
2017
Q2
$6.06M Sell
107,945
-46,466
-30% -$2.61M 0.01% 1267
2017
Q1
$6.05M Buy
154,411
+49,068
+47% +$1.92M 0.01% 1304
2016
Q4
$2.36M Buy
105,343
+38,937
+59% +$873K ﹤0.01% 2026
2016
Q3
$1.51M Buy
66,406
+3,884
+6% +$88.2K ﹤0.01% 2306
2016
Q2
$1.48M Sell
62,522
-28,069
-31% -$663K ﹤0.01% 2328
2016
Q1
$1.85M Buy
90,591
+34,132
+60% +$696K ﹤0.01% 2026
2015
Q4
$2.9M Buy
56,459
+2,668
+5% +$137K ﹤0.01% 1858
2015
Q3
$2.29M Sell
53,791
-31,286
-37% -$1.33M ﹤0.01% 2001
2015
Q2
$3.88M Buy
85,077
+19,498
+30% +$888K ﹤0.01% 1779
2015
Q1
$2.49M Buy
65,579
+26,696
+69% +$1.01M ﹤0.01% 1994
2014
Q4
$1.1M Buy
38,883
+20,081
+107% +$569K ﹤0.01% 2715
2014
Q3
$476K Sell
18,802
-24,443
-57% -$619K ﹤0.01% 3296
2014
Q2
$1.26M Buy
43,245
+26,833
+163% +$783K ﹤0.01% 2700
2014
Q1
$425K Buy
16,412
+2,157
+15% +$55.9K ﹤0.01% 3467
2013
Q4
$367K Buy
14,255
+5,923
+71% +$152K ﹤0.01% 3513
2013
Q3
$222K Buy
+8,332
New +$222K ﹤0.01% 3488